These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 13680329
1. Intravenous pulse cyclophosphamide--is it effective in children with steroid-resistant nephrotic syndrome? Alshaya HO, Al-Maghrabi JA, Kari JA. Pediatr Nephrol; 2003 Nov; 18(11):1143-6. PubMed ID: 13680329 [Abstract] [Full Text] [Related]
2. Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease. Haddad M, Kale A, Butani L. BMC Nephrol; 2021 Nov 29; 22(1):395. PubMed ID: 34839817 [Abstract] [Full Text] [Related]
3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J. Am J Kidney Dis; 2009 Jul 29; 54(1):51-8. PubMed ID: 19406543 [Abstract] [Full Text] [Related]
4. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy. Peña A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L, Alonso A, Picazo ML, Navarro M. Pediatr Nephrol; 2007 Nov 29; 22(11):1875-80. PubMed ID: 17876609 [Abstract] [Full Text] [Related]
5. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome. Mori K, Honda M, Ikeda M. Pediatr Nephrol; 2004 Nov 29; 19(11):1232-6. PubMed ID: 15322892 [Abstract] [Full Text] [Related]
6. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children]. Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical AssociationDepartment of Pediatrics, Nanjing General Hospital of Nanjing Military Command, Nanjing 21002, China. Email:njxzk@126.com.. Zhonghua Er Ke Za Zhi; 2014 Jul 29; 52(7):483-7. PubMed ID: 25224050 [Abstract] [Full Text] [Related]
7. Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome. Elhence R, Gulati S, Kher V, Gupta A, Sharma RK. Pediatr Nephrol; 1994 Feb 29; 8(1):1-3. PubMed ID: 8142205 [Abstract] [Full Text] [Related]
8. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome. Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A. Kidney Int; 2012 Nov 29; 82(10):1130-5. PubMed ID: 22763815 [Abstract] [Full Text] [Related]
9. Treatment of steroid resistant nephrotic syndrome in children. Kari JA, Halawani M. Saudi J Kidney Dis Transpl; 2010 May 29; 21(3):484-7. PubMed ID: 20427873 [Abstract] [Full Text] [Related]
10. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study. Kari JA, Halawani M, Mokhtar G, Jalalah SM, Anshasi W. Saudi J Kidney Dis Transpl; 2009 Sep 29; 20(5):854-7. PubMed ID: 19736491 [Abstract] [Full Text] [Related]
11. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J. Pediatr Nephrol; 2005 Jul 29; 20(7):914-9. PubMed ID: 15891923 [Abstract] [Full Text] [Related]
12. Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria. Olowu WA, Adelusola KA, Adefehinti O. Saudi J Kidney Dis Transpl; 2010 Sep 29; 21(5):979-90. PubMed ID: 20814150 [Abstract] [Full Text] [Related]
13. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy. Kanigicherla DAK, Hamilton P, Czapla K, Brenchley PE. Nephrology (Carlton); 2018 Jan 29; 23(1):60-68. PubMed ID: 27778424 [Abstract] [Full Text] [Related]
15. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN. Pediatr Nephrol; 2003 Apr 29; 18(4):351-6. PubMed ID: 12700961 [Abstract] [Full Text] [Related]
16. Steroid resistant nephrotic syndrome: role of histopathology. Gulati S, Sengupta D, Sharma RK, Sharma A, Gupta RK, Singh U, Gupta A. Indian Pediatr; 2006 Jan 29; 43(1):55-60. PubMed ID: 16465008 [Abstract] [Full Text] [Related]
17. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis. Gulati S, Kher V. Indian Pediatr; 2000 Feb 29; 37(2):141-8. PubMed ID: 10745408 [Abstract] [Full Text] [Related]
18. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology. Watanabe Y, Fujinaga S, Endo A, Endo S, Nakagawa M, Sakuraya K. Pediatr Nephrol; 2020 Dec 29; 35(12):2377-2381. PubMed ID: 32964318 [Abstract] [Full Text] [Related]
19. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial. Li H, Shi X, Shen H, Li X, Wang H, Li H, Xu G, Chen J. Clin Ther; 2012 May 29; 34(5):1112-20. PubMed ID: 22503105 [Abstract] [Full Text] [Related]
20. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions. Tejani A, Phadke K, Nicastri A, Adamson O, Chen CK, Trachtman H, Tejani C. Nephron; 1985 May 29; 41(2):170-3. PubMed ID: 4047274 [Abstract] [Full Text] [Related] Page: [Next] [New Search]